Biomarker: | NTRK2 fusion |
---|---|
Cancer: | Thyroid Gland Follicular Carcinoma |
Drug: | Rozlytrek (entrectinib) (ALK inhibitor, TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor, ROS1 inhibitor, JAK2 inhibitor, TNK2 inhibitor) |
Direction: | Sensitive |